Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-Center, Double-Blind, Randomized, Vehicle-Controlled, Dose-Range Study of DER 45 EV Gel, 1% and 5%, and Vehicle Gel in the Treatment of Rosacea

NCT00940992 is registered in ClinicalTrials.gov with Sol-Gel Technologies, Ltd. as lead sponsor.

NCT NCT00940992
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00940992 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-Center, Double-Blind, Randomized, Vehicle-Controlled, Dose-Range Study of DER 45 EV Gel, 1% and 5%, and Vehicle Gel in the Treatment of Rosacea
Lead sponsor
Sol-Gel Technologies, Ltd.
Phase
Phase 2
Overall status
Completed
Start date
January 31, 2012
Completion date
January 31, 2013
Enrollment
92 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

rosacea